John Klock - TechniScan Insider

TechniScan Inc -- USA Stock  

USD 0.0018  0.0002  12.50%

Chief Medical Officer

Dr. John C. Klock, M.D. is a Chief Medical Officer of TechniScan Inc. Dr. Klock had been the Chief Medical Officer of TechniScan Utah since June 2009. As a result of the Merger, effective as of October 9, 2009, he became the Company Chief Medical Officer. Prior to serving as the Chief Medical Officer, Dr. Klock had been a member of the Board of TechniScan Utah from February 2007 until June 2009. Dr. Klock received his medical degree from Tulane University, and completed his medical training at the University of CaliforniaSan Francisco and Massachusetts General Hospital. Dr. Klock is a boardcertified Internist and HematologistOncologist who practiced medicine and did research at the University of CaliforniaSan Francisco from 1970 to 1982. Since 1982, Dr, Klock was involved in the startup of five medical companies. Dr. Klock has authored over 70 peerreviewed medical and scientific publications and is listed as an inventor on 8 United States patents.
Age: 66  Executive Since 2009      

Management Efficiency

The company has return on total asset (ROA) of (234.43) % which means that it has lost $234.43 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of (5899.8) % meaning that it created substantial loss on money invested by shareholders.
The company currently holds 2.79 M in liabilities. TechniScan Inc has Current Ratio of 0.13 indicating that it has a negative working capital and may not be able to pay financial obligations when they are due.

Similar Executives

Found 5 records


George MoratisK2M Group Holdings Inc
Elizabeth DavilaAccuray Incorporated
Doug SherkAccuray Incorporated
Louis LavigneAccuray Incorporated
David CarawayNevro Corp

Entity Summary

TechniScan, Inc., a development stage company, engages in the research, development, and commercialization of non-invasive medical imaging products for the detection and diagnosis of breast cancer. It intends to develop the Warm Bath Ultrasound system, an ultrasound-based imaging device that provides radiologists with information about the bulk properties of tissue in the breast, as well as images of the tissue structure. TechniScan operates under Medical Appliances Equipment classification in USA and traded on OTC Market. It employs 5 people.TechniScan Inc (TSNI) is traded on OTC Market in USA. It is located in 3216 South Highland Drive and employs 5 people.

Did you try this?

Run Equity Search Now

Equity Search

Search for activelly-traded equities including funds and ETFs from over 30 global markets
Hide  View All  NextLaunch Equity Search
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add TechniScan Inc to your portfolio

Top Management

TechniScan Inc Leadership Team
David Robinson, CEO
Cheryl Cook, Director
Joseph Pepper, Director, MBA
Kenneth Hungerford, Chairman
Barry Hanover, Director
John Klock, Executive
Richard Stanley, Director
Steven Passey, CFO
Gerald Richardson, Director

Stock Performance

TechniScan Performance Indicators